ELIMINATION OF PINDOLOL IN LIVER-DISEASE

被引：10

作者：

OHNHAUS, EE

MUNCH, U

MEIER, J

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 22卷 / 03期

关键词：

D O I：

10.1007/BF00545223

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：247 / 251

页数：5

共 23 条

[1] PHENAZONE METABOLISM IN PATIENTS WITH LIVER-DISEASE [J].

ANDREASEN, PB ;

GREISEN, G .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1976, 6 (01) :21-26

[2]

ANDREASEN PB, 1974, EUR J CLIN INVEST, V4, P129

[3] LIVER-DISEASE AND DRUG-THERAPY [J].

BLACK, M .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :1051-1057

[4] DETERMINANTS OF SERUM ANTIPYRINE HALF-LIVES IN PATIENTS WITH LIVER-DISEASE [J].

BRANCH, RA ;

HERBERT, CM ;

READ, AE .

GUT, 1973, 14 (07) :569-573

[5]

BRODIE BB, 1949, J BIOL CHEM, V179, P25

[6]

BRODIE BB, 1950, J PHARMACOL EXP THER, V98, P97

[7] PHARMACOKINETICS OF PINDOLOL IN MAN [J].

GUGLER, R ;

HEROLD, W ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :17-24

[8] SINGLE AND MULTIPLE DOSE PHARMACOKINETICS OF PINDOLOL [J].

GUGLER, R ;

BODEM, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (01) :13-16

[9]

HVIDBERG EF, 1974, CLIN PHARMACOL THER, V15, P171

[10]

KLOTZ U, 1979, CLIN PHARMACOL THER, V26, P221

← 1 2 3 →